checkAd
    PROCEPT BioRobotics Corporation Aktie
    64,01
     
    USD
    -0,73 %
    -0,47 USD
    Letzter Kurs 13:00:00 Nasdaq
    64,44
     
    USD
    1.200 STK
    Geldkurs 28.05.24
    64,55
     
    USD
    600 STK
    Briefkurs 28.05.24
    ISIN: US74276L1052 · WKN: A3C3AJ · SYM: PRCT · USA

    Neueste Nachrichten

    PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
    13.05.24 · globenewswire · PROCEPT BioRobotics Corporation
    Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
    06.05.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
    01.05.24 · globenewswire · PROCEPT BioRobotics Corporation
    Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
    29.04.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
    23.04.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
    04.04.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
    02.04.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
    27.02.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
    12.02.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
    08.01.24 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
    13.11.23 · globenewswire · PROCEPT BioRobotics Corporation
    PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
    16.10.23 · globenewswire · PROCEPT BioRobotics Corporation